Personalis Inc (NAS:PSNL)
$ 5.87 -0.39 (-6.23%) Market Cap: 497.15 Mil Enterprise Value: 398.65 Mil PE Ratio: 0 PB Ratio: 2.49 GF Score: 61/100

Personalis Inc at UBS Global Healthcare Conference (Virtual) Transcript

May 19, 2020 / 07:50PM GMT
Release Date Price: $11.52 (-3.60%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Good afternoon. Welcome to another afternoon session here at the UBS Healthcare Conference. My name is Dan Brennan. I cover life science tools, diagnostics and pharma services for UBS. Really pleased to be joined with me here virtually on stage with senior executives from Personalis. With me is John West, CEO; and Aaron Tachibana, who is the CFO. Please feel free to -- if you're on the webcast, just pose a question that way, if you'd like. I'm happy to glance at it during the presentation and see if I can get it posed to John and Aaron. But first, I wanted to say, again, welcome, gentlemen. And I think, John, is going to make some opening remarks, maybe give a little perspective on the business for those who aren't as informed or knowledgeable on it, and then we can go through Q&A. So once again, guys, thank you.

John Stephen West
Personalis, Inc. - Co-Founder, CEO, President & Director

Great. Well, thank you very much. I'm happy

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot